NCT05889598 — Loughborough University cancer immunotherapy trial
Resistance Exercise Training to Improve Bone and Articular Cartilage Health in Women
Registry record
| Registry ID | NCT05889598 ↗ |
|---|---|
| Lead sponsor | Loughborough University |
| Collaborators | Versus Arthritis |
| Phase | Phase NA |
| Status | Active Not Recruiting |
| Indication | Osteoporosis, Osteoarthritis |
| Enrollment | 110 participants (target) |
| Start date | 2022-03-01 |
| Primary completion | 2026-12-31 (est.) |
| Last registry update | 21 Apr 2026 |
Every field above is mirrored from the study record on ClinicalTrials.gov (NCT05889598), which the sponsor maintains and which carries the full protocol summary, eligibility criteria, sites and contacts. No neoantigen vaccine is approved anywhere yet — every program here is investigational, and inclusion is not an endorsement. See the methodology for how the tracker is built.
Where this fits
No modality, tumor or player hub covers this study yet. Browse the field map for the axes the daily brief does track.
Related trials
FAQ
What phase is NCT05889598?
NCT05889598 (Resistance Exercise Training to Improve Bone and Articular Cartilage Health in Women) is registered on ClinicalTrials.gov as Phase NA, sponsored by Loughborough University.
Is NCT05889598 recruiting?
As of the 2026-04-21 registry update, NCT05889598 is listed as "Active Not Recruiting". Eligibility criteria, study sites and contacts are maintained by the sponsor on the ClinicalTrials.gov record.
Who is running NCT05889598?
The lead sponsor is Loughborough University. Collaborators: Versus Arthritis.
What condition does NCT05889598 study?
The registered conditions are Osteoporosis, Osteoarthritis. Primary completion is listed as 2026-12-31 (estimated).
Are results available for NCT05889598?
neoag.ai mirrors the registry's factual fields — sponsor, phase, status and dates — and does not publish trial results. Any posted results, publications, or outcome measures appear on the ClinicalTrials.gov record for NCT05889598.
Back to the full neoantigen vaccine trial tracker — 107 studies, refreshed daily from ClinicalTrials.gov. Background: primer, glossary, and the companies landscape.